Is IMAX Corporation (IMAX) stock undervalued in 2026?

2026-08-03 · By Lubin Danilo, founder of Lubin Investment

IMAX: see the full analysis on Lubin Investment

IMAX Corporation validates all 10 of my quality criteria, a rare perfect score in my screener, AND my model shows a 36.9% discount versus its fair buy price. An uncommon combination: the most recognized giant-screen cinema brand in the world, at a price my model genuinely calls cheap. Here is why.

The cinema brand everyone recognizes, without knowing it trades on the stock market

Almost everyone has seen, on a movie poster, the words "The IMAX Experience." It is one of the few entertainment brands for which a moviegoer will happily pay more for a ticket, in exchange for a giant screen, proprietary sound and specially reworked picture. What many do not know is that IMAX Corporation is a publicly traded company, and that this reputation translates into concrete financial numbers, not just a brand image.

The immediate trigger is the second-quarter 2026 report, released July 23: earnings per share of $0.43, far above the $0.2851 analysts expected, a beat of more than 50%, and revenue of $102.8 million against $95.6 million expected. The stock jumped 6.7% pre-market that day. The quarter also marked the strongest second-quarter installation pace in a decade (38 new systems), and international network growth outside China of 9% year over year. But as always, one good quarter is not enough: it is the five-year trend that matters for judging the real quality of the business.

A model that owns neither theaters nor films: licensing an experience

IMAX does not build or run any movie theaters. Its business is signing long-term agreements with exhibitors (the major cinema chains) to install its proprietary projection and sound systems in a select handful of auditoriums, and digitally reworking blockbuster films frame by frame through its DMR (digital remastering) process to optimize them for the giant IMAX format. In exchange, IMAX earns a share of the price premium moviegoers agree to pay for that experience, plus revenue from selling or leasing its systems, without ever owning a single cinema seat.

This model explains profitability far above that of a traditional theater operator, a business usually commoditized and low-margin. After decades of consistent quality, the IMAX brand has become a selling point in its own right that moviegoers actively seek out and pay more for, a rare phenomenon in film exhibition. This pricing power shows up directly in the numbers: a free cash flow margin of 21.8% of revenue, more than double what is typical for the sector, and a 30.5% cash return on capital employed, an excellent level explained by how little capital stays tied up once a system is installed at an exhibitor.

Growth that is accelerating (but just under my threshold)

Five-year sales growth comes in at 9.4% a year, just under my 10% threshold: that is not a failure of my filter, only a warning, given how small the gap is. What matters far more is what this moderate revenue growth produces once combined with expanding margins and buybacks (the share count has fallen 1.39% a year): free cash flow per share has climbed 91.5% a year over five years, a nearly explosive pace.

Two other signals confirm the quality of this cash conversion. First, the rate at which accounting profit turns into real cash reaches 216%: more than double the reported profit becomes cash actually available, a rare and very positive signal (when many companies struggle to convert even 100% of their accounting profit into cash). Second, the net cash conversion cycle (the time between paying suppliers and collecting from customers) stands at 139 days and is shrinking by 15.8 days each year: IMAX becomes more efficient at managing its working capital every year, a sign of continuous operational improvement.

The growth strategy: China, laser, and the world beyond

IMAX is targeting a record $1.4 billion in global box office for 2026, 160 to 175 new installations, and adjusted EBITDA margins of at least the mid-40% range. In China, where giant-screen cinema has become a genuine cultural phenomenon, IMAX holds a backlog of nearly 200 sites, prioritizing higher-tier cities over the pre-pandemic mall-driven strategy, and progressively upgrading older systems to laser technology, which raises the average premium ticket price. Six mainland Chinese theaters equipped with the most powerful format (GT, giant laser screen) have become genuine pilgrimage sites for film fans.

Beyond China, Australia and Japan remain under-penetrated markets with strong potential (a new deal with the HOYTS chain in Australia), and India, also significantly under-equipped, is being targeted through big local (Bollywood) releases and longer installation timelines than elsewhere.

The price: cheap versus its own history, expensive versus its sector

IMAX currently trades at 32.5 times its free cash flow (P/FCF), a level I would call rich in absolute terms. Set against its own five-year history, that multiple sits at the 37.5th percentile: IMAX is fairly cheap relative to itself, below its own historical median.

Compared with its entertainment-sector peers (sector median of 25.1 times), IMAX sits at the 69th percentile: it is therefore pricier than most of its direct comparables on this metric alone. Taken in isolation, that could be discouraging. But the third step, the verdict, tells a different story: my model does not rely on the observed multiple alone, it projects the five-year cash-per-share trajectory, and that trajectory is currently accelerating very strongly (+91.5% a year). Paying 32.5 times the cash of a company whose cash per share is exploding is nothing like paying the same multiple for a company whose cash is stagnant. That difference in trajectory is why my model puts the fair buy price at $69.81, against a price of around $51, a 36.9% discount.

The real debate: will the giant-screen rebound last?

The whole IMAX thesis rests on a tension. On one side, giant-screen culture is booming in China, the laser upgrade is raising average ticket prices, international expansion targets still under-equipped markets, and the quality score is perfect. On the other, sales growth stays just under my threshold, a sector (film exhibition) facing structural headwinds since the rise of streaming, and a good part of the explosive cash-per-share growth comes from buybacks and margin expansion rather than pure volume growth. IMAX also depends on the studio release calendar: without blockbuster films to remaster, the machine slows quickly. If you believe China's momentum and international expansion more than offset this risk, the perfect score and the model's discount justify keeping a close eye on IMAX.

How I settle it

IMAX combines a perfect quality score, rare in my screener, with a genuine discount by my model, an uncommon combination I do not come across every day. That is not a guarantee the stock will rise, but it is exactly the kind of setup that deserves close attention. You can follow these numbers live on IMAX's analysis page, and understand in detail how I calculate this fair buy price in my full methodology.

IMAX Corporation validates all 10 of my quality criteria (a perfect score), driven by free cash flow per share up 91.5% a year over five years and a 21.8% cash margin.
The model: IMAX owns neither theaters nor films. It licenses its giant-format projection technology and remasters films (the DMR process) in exchange for a share of the premium price moviegoers pay, without heavy real estate capital.
Strong second-quarter 2026 results (EPS of $0.43 beating consensus by more than 50%), driven by the strongest installation pace in a decade and expansion in China (nearly 200 sites in backlog, laser upgrades).
P/FCF of 32.5 times: relatively cheap versus its own history (37.5th percentile) but expensive versus the entertainment sector (69th percentile, median 25.1 times).
My model still flags a 36.9% discount (fair buy price of $69.81 against a price around $51) thanks to a sharply accelerating cash-per-share trajectory.

FAQ

Does IMAX own movie theaters?

No. IMAX licenses its projection and sound technology to third-party exhibitors, and remasters films into the giant format (the DMR process). It earns a share of the premium price moviegoers pay, without ever owning a theater.

Why is IMAX's cash margin so high?

Because the IMAX brand allows it to charge a premium moviegoers agree to pay, a real pricing power rare in film exhibition. That shows up as a 21.8% free cash flow margin, more than double the sector norm.

Isn't a 32.5x P/FCF expensive for IMAX?

It is fairly cheap versus its own history (37.5th percentile) but expensive versus the entertainment sector (69th percentile). My model looks at the cash-per-share trajectory, which is accelerating at 91.5% a year, which in its view justifies a 36.9% discount despite the seemingly rich multiple.

What is IMAX's growth strategy for 2026?

A target of $1.4 billion in global box office, 160 to 175 new installations, laser upgrades of its systems in China (nearly 200 sites in backlog), and expansion into Australia, Japan and India, markets that remain under-equipped.

Is IMAX undervalued in 2026?

By my model, yes: a 36.9% discount (fair buy price of $69.81 against a price around $51), combined with a perfect quality score. This is not personalized investment advice, do your own research before any decision.

About the author

Written by Lubin Danilo, founder of Lubin Investment. A self-taught individual investor, I find fundamental analysis fascinating, and it has delivered excellent results. For three years now, my performance has beaten the S&P 500. But analyzing every stock took too much time: sites with incomplete data, calculation methods and criteria never aligned with mine. And spotting the best stocks was just as time-consuming, even with my own well-defined checklist. So I put my software development background to work to build this software, base my investment strategy on its results, and share it with people who share the same passion as me. It judges a company's quality and its price separately, using criteria drawn from the financial literature (Warren Buffett, Michael Mauboussin, Aswath Damodaran).